These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28338827)

  • 1. Strategies for halting the rise of multidrug resistant TB epidemics: assessing the effect of early case detection and isolation.
    Espindola AL; Varughese M; Laskowski M; Shoukat A; Heffernan JM; Moghadas SM
    Int Health; 2017 Mar; 9(2):80-90. PubMed ID: 28338827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the transmission risk of multidrug-resistant Mycobacterium tuberculosis epidemics in regions of Taiwan.
    Liao CM; Lin YJ
    Int J Infect Dis; 2012 Oct; 16(10):e739-47. PubMed ID: 22818291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
    Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases.
    Fox GJ; Schaaf HS; Mandalakas A; Chiappini E; Zumla A; Marais BJ
    Clin Microbiol Infect; 2017 Mar; 23(3):147-153. PubMed ID: 27592087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Resistant tuberculosis - primary transmission and management.
    Outhred AC; Britton PN; Marais BJ
    J Infect; 2017 Jun; 74 Suppl 1():S128-S135. PubMed ID: 28646952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis.
    Kendall EA; Azman AS; Cobelens FG; Dowdy DW
    PLoS One; 2017; 12(3):e0172748. PubMed ID: 28273116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings.
    Nardell E; Dharmadhikari A
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1233-43. PubMed ID: 20843413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
    Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs.
    Gurjav U; Erkhembayar B; Burneebaatar B; Narmandakh E; Tumenbayar O; Hill-Cawthorne GA; Marais BJ; Sintchenko V
    Tuberculosis (Edinb); 2016 Dec; 101():49-53. PubMed ID: 27865397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains.
    McBryde ES; Meehan MT; Doan TN; Ragonnet R; Marais BJ; Guernier V; Trauer JM
    Int J Infect Dis; 2017 Mar; 56():14-20. PubMed ID: 28163165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing multidrug-resistant tuberculosis in penitentiary hospitals and in the general population of the former Soviet Union.
    Portaels F; Rigouts L; Bastian I
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):582-8. PubMed ID: 10423220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients.
    Wenger PN; Otten J; Breeden A; Orfas D; Beck-Sague CM; Jarvis WR
    Lancet; 1995 Jan; 345(8944):235-40. PubMed ID: 7823719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scenario Analysis for Programmatic Tuberculosis Control in Western Province, Papua New Guinea.
    Trauer JM; Denholm JT; Waseem S; Ragonnet R; McBryde ES
    Am J Epidemiol; 2016 Jun; 183(12):1138-48. PubMed ID: 27199387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes.
    Leimane V; Leimans J
    Euro Surveill; 2006; 11(3):29-33. PubMed ID: 16567876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.